CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 
 
Wright Investors Service Perspectives
 
 
 
     
  The Wright Reports site is no longer hosted or operated by Manta. Please review the following:
1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later) 		 
     
 
 
 
Viromed Company Ltd Company Snapshot
Business Description:
Viromed Company Ltd operates in the Biological products exc. diagnostic sector. ViroMed Co., Ltd. is a Korea-based company engaged in the development and manufacture of biopharmaceuticals. The Company produces products for therapy of various disease areas, including cardiovascular diseases, such as peripheral artery disease and coronary artery disease; neuropathy diseases, such as diabetic peripheral neuropathy disease; cancer, such as breast cancer and thrombocytopenia; arthritis, such as osteoarthritis, and allergy, such as atopic dermatitis and muscular fatigue. The Company's products include VM202-PAD, VM202-CAD, VM202-DPN, VM206, VM505, VM501, PG201, PG102, Allex, Allex-i, and HX108CS. The Company distributes its products within domestic market and to overseas markets, including China, America, Japan, Hong Kong, Singapore and Europe. In our complete report available for purchase the company is compared to: Hans Biomed Corporation, Choong Ang Vaccine Laboratory and Medy-Tox Incorporation.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Viromed Company Ltd
  Stock Performance Chart for Viromed Company Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (2/3/2012): 20,250
(Figures in Korean Won)
1 Week 15.7%   13 Weeks 27.4%  
4 Weeks 78.4%   52 Weeks 144.9%  
 
Viromed Company Ltd Key Data:
  Ticker: 084990 Country: KOREA (SOUTH)
  Exchanges: SEO Major Industry: Drugs, Cosmetics & Health Care
    Sub Industry: Ethical Drug Manufacturers
  2010 Sales 4,653,874,000
(Year Ending Jan 2011).		 Employees: 62
  Currency: Korean Won Market Cap: 235,678,045,500
  Fiscal Yr Ends: December Shares Outstanding: 11,638,422
  Share Type: Common Closely Held Shares: 3,465,422
 
 
Featured Products and Services
  
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.